Skip to content

Clinical trials

Active, not recruiting Adenocarcinoma of Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Status: Active, not recruiting Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20112
20151
20161
20172
20192
20203
20212
20222
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Alliance for Clinical Trials in Oncology2
M.D. Anderson Cancer Center2
Azienda USL Reggio Emilia - IRCCS1
Hacettepe University1
Jonsson Comprehensive Cancer Center1
Memorial Sloan Kettering Cancer Center1
Pfizer1
SOLTI Breast Cancer Research Group1
SWOG Cancer Research Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung20
Lung Neoplasms12
Carcinoma, Non-Small-Cell Lung10
Adenocarcinoma, Bronchiolo-Alveolar4
Breast Neoplasms2
Carcinoma, Renal Cell2
Colorectal Neoplasms2
Melanoma2
Neoplasm Metastasis2
Neoplasms2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.